Total Payments
$4,365
2023 Payments
$196.77
Companies
35
Transactions
265
Medicare Patients
2,816
Medicare Billing
$246,013
Payment Breakdown by Category
Food & Beverage$4,341 (99.5%)
Education$23.79 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,341 | 260 | 99.5% |
| Education | $23.79 | 5 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,109 | 93 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $1,004 | 38 | $0 (2022) |
| Lilly USA, LLC | $236.16 | 17 | $0 (2023) |
| Allergan, Inc. | $208.21 | 12 | $0 (2020) |
| Shire North American Group Inc | $205.73 | 15 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $202.60 | 13 | $0 (2021) |
| PFIZER INC. | $144.46 | 9 | $0 (2020) |
| Kowa Pharmaceuticals America, Inc. | $134.45 | 2 | $0 (2019) |
| ABBVIE INC. | $130.32 | 7 | $0 (2023) |
| Medtronic Vascular, Inc. | $126.34 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $196.77 | 11 | Lilly USA, LLC ($53.21) |
| 2022 | $119.25 | 7 | GlaxoSmithKline, LLC. ($30.50) |
| 2021 | $368.83 | 22 | Novo Nordisk Inc ($139.03) |
| 2020 | $585.08 | 42 | Novo Nordisk Inc ($225.87) |
| 2019 | $826.83 | 64 | Novo Nordisk Inc ($228.04) |
| 2018 | $1,077 | 59 | AstraZeneca Pharmaceuticals LP ($338.89) |
| 2017 | $1,191 | 60 | AstraZeneca Pharmaceuticals LP ($411.19) |
All Payment Transactions
265 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/27/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Diabetes | ||||||
| 05/30/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Diabetes | ||||||
| 05/18/2023 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Hyperthyroidism | ||||||
| 05/04/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Oncology | ||||||
| 04/13/2023 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 04/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: RESPIRATORY | ||||||
| 03/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2023 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Neurology | ||||||
| 03/21/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Diabetes | ||||||
| 02/23/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $19.35 | General |
| 01/04/2023 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Neurology | ||||||
| 11/17/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Diabetes | ||||||
| 10/25/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: RESPIRATORY | ||||||
| 10/13/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Diabetes | ||||||
| 09/27/2022 | Antares Pharma, Inc. | XYOSTED (Drug), TLANDO, NOCDURNA | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/08/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Inflammation | ||||||
| 08/23/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: RESPIRATORY | ||||||
| 08/03/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/22/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Diabetes | ||||||
| 07/20/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Diabetes | ||||||
| 07/01/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Diabetes | ||||||
| 06/10/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: RESPIRATORY | ||||||
| 06/03/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 355 | 387 | $55,161 | $23,970 |
| 2022 | 8 | 250 | 268 | $36,723 | $17,714 |
| 2021 | 12 | 719 | 1,114 | $162,053 | $67,343 |
| 2020 | 22 | 1,492 | 2,325 | $322,970 | $136,986 |
Total Patients
2,816
Total Services
4,094
Medicare Billing
$246,013
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 60 | 78 | $17,316 | $6,109 | 35.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 46 | 46 | $7,590 | $5,962 | 78.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 41 | 45 | $13,410 | $4,569 | 34.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 49 | 49 | $8,526 | $3,955 | 46.4% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 50 | 50 | $2,750 | $1,286 | 46.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 49 | 49 | $2,450 | $921.69 | 37.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 47 | 47 | $1,739 | $884.07 | 50.8% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 13 | 23 | $1,380 | $284.05 | 20.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 49 | $10,878 | $4,602 | 42.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 30 | 30 | $4,950 | $3,953 | 79.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 28 | $8,344 | $3,707 | 44.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 36 | 36 | $6,264 | $2,973 | 47.5% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 38 | 38 | $2,090 | $990.16 | 47.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 31 | 31 | $1,550 | $596.01 | 38.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 31 | 31 | $1,147 | $584.66 | 51.0% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 20 | 25 | $1,500 | $309.23 | 20.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 220 | 482 | $103,508 | $42,045 | 40.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 98 | 141 | $20,261 | $7,774 | 38.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 50 | 50 | $8,250 | $6,761 | 81.9% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 62 | 62 | $10,788 | $3,953 | 36.6% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2021 | 61 | 61 | $3,355 | $1,635 | 48.7% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 45 | 127 | $7,620 | $1,588 | 20.8% |
| 0031A | Adm sarscov2 vac ad26 .5ml | Office | 2021 | 37 | 37 | $1,850 | $1,236 | 66.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 51 | 51 | $1,887 | $989.40 | 52.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $2,900 | $799.21 | 27.6% |
About Dr. Daniel Freeland, DO
Dr. Daniel Freeland, DO is a Family Medicine healthcare provider based in Lakeway, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336258847.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Freeland, DO has received a total of $4,365 in payments from pharmaceutical and medical device companies, with $196.77 received in 2023. These payments were reported across 265 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($4,341).
As a Medicare-enrolled provider, Freeland has provided services to 2,816 Medicare beneficiaries, totaling 4,094 services with total Medicare billing of $246,013. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Lakeway, TX
- Active Since 08/29/2006
- Last Updated 04/22/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1336258847
Products in Payments
- FARXIGA (Drug) $810.83
- Ozempic (Drug) $619.14
- Saxenda (Drug) $358.06
- VYVANSE (Drug) $195.94
- Trintellix (Drug) $166.65
- Livalo (Drug) $134.45
- ClosureFast (Device) $126.34
- BYDUREON (Drug) $123.70
- UBRELVY (Drug) $120.55
- Victoza (Drug) $114.13
- TRULICITY (Drug) $102.98
- CHANTIX (Drug) $102.97
- Xofluza (Drug) $78.98
- MOUNJARO (Drug) $77.50
- VRAYLAR (Drug) $73.60
- JARDIANCE (Drug) $69.45
- XIFAXAN (Drug) $69.18
- MYDAYIS (Drug) $64.79
- TRELEGY ELLIPTA (Drug) $57.76
- SHINGRIX (Biological) $51.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lakeway
Dr. David Gabriel, M.d, M.D
Family Medicine — Payments: $3,954
Family Medicine $3,954
Dr. Edward Pratt, M.d, M.D
Family Medicine — Payments: $3,188
Family Medicine $3,188
Barbara Kiersz Mueller, D.o., B.s., A.a, D.O., B.S., A.A
Family Medicine — Payments: $1,500
Family Medicine $1,500
Daniel Coffey, Md, MD
Family Medicine — Payments: $977.87
Family Medicine $977.87
Dr. Ronald Dewitt, M.d, M.D
Family Medicine — Payments: $581.01
Family Medicine $581.01
Michael Esmay, Md, MD
Family Medicine — Payments: $209.56
Family Medicine $209.56